688 related articles for article (PubMed ID: 30476973)
1. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
[TBL] [Abstract][Full Text] [Related]
2. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau.
Roth A; Jensen H; Garly ML; Djana Q; Martins CL; Sodemann M; Rodrigues A; Aaby P
Pediatr Infect Dis J; 2004 Jun; 23(6):544-50. PubMed ID: 15194836
[TBL] [Abstract][Full Text] [Related]
3. BCG vaccination reaction in low birth weight infants.
Kaur S; Faridi MM; Agarwal KN
Indian J Med Res; 2002 Aug; 116():64-9. PubMed ID: 12592992
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.
Saroha M; Faridi MM; Batra P; Kaur I; Dewan DK
Hum Vaccin Immunother; 2015; 11(12):2864-71. PubMed ID: 26431252
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
6. Tuberculin conversion and leukocyte migration inhibition test after BCG vaccination in newborn infants.
Faridi M; Kaur S; Krishnamurthy S; Kumari P
Hum Vaccin; 2009 Oct; 5(10):690-5. PubMed ID: 19855160
[TBL] [Abstract][Full Text] [Related]
7. Tuberculin reaction and BCG scar: association with infant mortality.
Timmermann CA; Biering-Sørensen S; Aaby P; Fisker AB; Monteiro I; Rodrigues A; Benn CS; Ravn H
Trop Med Int Health; 2015 Dec; 20(12):1733-44. PubMed ID: 26426863
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
[TBL] [Abstract][Full Text] [Related]
9. Bacillus Calmette-Guerin vaccination in preterm infants.
Okan F; Karagoz S; Nuhoglu A
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1337-41. PubMed ID: 17167949
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2004; (1):CD000361. PubMed ID: 14973955
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2001; (2):CD000361. PubMed ID: 11405962
[TBL] [Abstract][Full Text] [Related]
13. Tuberculin response in preterm infants after BCG vaccination at birth.
Sedaghatian MR; Kardouni K
Arch Dis Child; 1993 Sep; 69(3 Spec No):309-11. PubMed ID: 8215572
[TBL] [Abstract][Full Text] [Related]
14. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2013 Jul; (7):CD000361. PubMed ID: 23821390
[TBL] [Abstract][Full Text] [Related]
16. Bacille Calmette Guérin vaccination in pre-term infants.
Sedaghatian MR; Hashem F; Moshaddeque Hossain M
Int J Tuberc Lung Dis; 1998 Aug; 2(8):679-82. PubMed ID: 9712284
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women.
Thaithumyanon P; Thisyakorn U; Punnahitananda S; Praisuwanna P; Ruxrungtham K
Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):482-6. PubMed ID: 11289006
[TBL] [Abstract][Full Text] [Related]
18. Tuberculin conversion following BCG vaccination in preterm infants.
Dawodu AH
Acta Paediatr Scand; 1985 Jul; 74(4):564-7. PubMed ID: 4024927
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2000; (2):CD000361. PubMed ID: 10796199
[TBL] [Abstract][Full Text] [Related]
20. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.
Pang Y; Kang W; Zhao A; Liu G; Du W; Xu M; Wang G; Zhao Y; Zheng S
Vaccine; 2015 Jan; 33(1):209-13. PubMed ID: 25454854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
